Carbamazepine-induced antinuclear antibodies and systemic lupus erythematosus-like syndrome.
 A 20-year-old woman developed a systemic lupus erythematosus (SLE)-like syndrome and a positive antinuclear antibody (ANA) soon after initiation of carbamazepine (CBZ) therapy.
 Symptoms and serology became normal after CBZ was discontinued.
 CBZ-induced SLE is an important but underecognized phenomenon.
